Tussicaps

Catarrh, Migraine, Coughing + 55 more

Treatment

6 FDA approvals

20 Active Studies for Tussicaps

What is Tussicaps

Chlorpheniramine

The Generic name of this drug

Treatment Summary

Hydrocodone is a powerful painkiller that is usually taken in combination with acetaminophen to treat moderate to severe pain. It used to be used as a cough suppressant but has since been replaced by dextromethorphan in cough and cold medicines. Hydrocodone’s more potent metabolite, hydromorphone, is sometimes prescribed for severe pain. Hydrocodone was first approved for use by the FDA in 1943 as part of the cough suppressant syrup Hycodan.

Rynatuss

is the brand name

Tussicaps Overview & Background

Brand Name

Generic Name

First FDA Approval

How many FDA approvals?

Rynatuss

Chlorpheniramine

1960

47

Approved as Treatment by the FDA

Chlorpheniramine, also known as Rynatuss, is approved by the FDA for 6 uses including Acute Bronchitis and Cold .

Acute Bronchitis

Used to treat Cough in combination with Hydrocodone

Cold

Used to treat Cold in combination with Hydrocodone

Allergic Rhinitis (AR)

Allergy to Tree Pollen

upper respiratory symptoms

Used to treat upper respiratory symptoms in combination with Hydrocodone

Hypersensitivity

Used to treat Allergic Reaction in combination with Hydrocodone

Effectiveness

How Tussicaps Affects Patients

Hydrocodone is a painkiller that works by blocking pain signals from reaching the brain. It also produces feelings of euphoria, slowed breathing, and drowsiness.

How Tussicaps works in the body

Hydrocodone works by targeting two kinds of opioid receptors in the body: mu and delta. It binds to these receptors, stopping nerve signals that would normally lead to pain. It also affects the brain's reward system, producing a feeling of pleasure. Hydrocodone also has an inhibitory effect on GABAergic neurons in the ventral tegmental area, leading to sedation and respiratory depression. The effects of delta opioid receptors are not as well studied but may also contribute to pain relief.

When to interrupt dosage

The recommended measure of Tussicaps is contingent upon the determined illness, including Coughing, Coughing and Chronic Pain. The exact amount of dosage is dependent upon the method of administration (e.g. Tablet, extended release - Oral or Tablet - Oral) featured in the table below.

Condition

Dosage

Administration

Sinusitis

, 1.0 mg/mL, 0.2 mg/mL, 2.0 mg, 4.0 mg, 8.0 mg, 2.0 mg/mL, 2.0 mL/mL, 4.0 mg/mL, 12.0 mg, 0.002 mg/mg, 0.0004 mg/mg, 0.75 mg/mL, 8.0 mg/mL, 9.0 mg, 1.995 mg/mL, 0.999 mg/mL, 1.001 mg/mL, 0.01 mg/mg, 0.03 mg/mg, 0.00025 mg/mg, 0.25 mg/mL, 0.6 mg/mL, 1.05 mg, 1.0 mg, 0.5 mg, 0.0125 mg/mg, 1.25 mg/mL, 0.667 mg, 4.5 mg/mL, 1.25 mg, 2.0 mg/mg, 0.002 mg, 24.0 mg, 0.4 mg/mL, 3.0 mg, 2.8 mg/mL, 3.5 mg, 0.001 mg/mg, 6.25 mg, 5.0 mg/mL, 0.1 mg/mL, 0.8 mg/mL, 5.0 mg, 4.5 mg, 10.0 mg/mL, 0.00087 mg/mg, 2.5 mg/mL, 0.004 mg/mg, 0.5 mg/mL, 1.5 mg/mL

, Liquid - Oral, Oral, Liquid, Solution, Solution - Oral, Tablet - Oral, Capsule, extended release, Capsule, extended release - Oral, Tablet, film coated - Oral, Tablet, Tablet, film coated, Powder, for solution, Capsule, liquid filled, Tablet, effervescent - Oral, Granule, effervescent - Oral, Granule, effervescent, Tablet, effervescent, Capsule, liquid filled - Oral, Powder, for solution - Oral, Suspension, Suspension - Oral, Capsule, Capsule - Oral, Tablet, coated - Oral, Tablet, coated, Tablet, extended release - Oral, Tablet, extended release, Syrup, Syrup - Oral, Suspension, extended release - Oral, Suspension, extended release, Kit, Tablet, film coated, extended release - Oral, Tablet, film coated, extended release, Capsule, gelatin coated, Capsule, gelatin coated - Oral, Powder, Tablet, sugar coated, Tablet, sugar coated - Oral, Granule, Granule - Oral, Powder - Oral, Tablet, multilayer - Oral, Tablet, multilayer, Lozenge, Lozenge - Oral, Tablet, chewable, Tablet, chewable - Oral, Capsule, delayed release pellets, Capsule, delayed release pellets - Oral, Granule, for solution, Granule, for solution - Oral, Liquid; Tablet - Oral; Parenteral, Oral; Parenteral, Liquid; Tablet, Liquid - Intramuscular; Intravenous; Subcutaneous, Intramuscular; Intravenous; Subcutaneous, Intramuscular; Oral; Subcutaneous, Liquid; Tablet - Intramuscular; Oral; Subcutaneous, Kit; Tablet - Oral, Kit; Tablet, Kit; Powder - Oral, Kit; Powder, Kit - Oral, Kit; Tablet; Tablet, extended release - Oral, Kit; Tablet; Tablet, extended release, Kit; Powder, for solution - Oral, Topical, Liquid - Topical, Kit; Powder, for solution, Solution / drops, Solution / drops - Oral, Solution / drops - Nasal, Tablet, multilayer, extended release, Tablet, multilayer, extended release - Oral, Nasal, Capsule, coated pellets, Capsule, coated pellets - Oral

Seasonal Allergic Conjunctivitis

, 1.0 mg/mL, 0.2 mg/mL, 2.0 mg, 4.0 mg, 8.0 mg, 2.0 mg/mL, 2.0 mL/mL, 4.0 mg/mL, 12.0 mg, 0.002 mg/mg, 0.0004 mg/mg, 0.75 mg/mL, 8.0 mg/mL, 9.0 mg, 1.995 mg/mL, 0.999 mg/mL, 1.001 mg/mL, 0.01 mg/mg, 0.03 mg/mg, 0.00025 mg/mg, 0.25 mg/mL, 0.6 mg/mL, 1.05 mg, 1.0 mg, 0.5 mg, 0.0125 mg/mg, 1.25 mg/mL, 0.667 mg, 4.5 mg/mL, 1.25 mg, 2.0 mg/mg, 0.002 mg, 24.0 mg, 0.4 mg/mL, 3.0 mg, 2.8 mg/mL, 3.5 mg, 0.001 mg/mg, 6.25 mg, 5.0 mg/mL, 0.1 mg/mL, 0.8 mg/mL, 5.0 mg, 4.5 mg, 10.0 mg/mL, 0.00087 mg/mg, 2.5 mg/mL, 0.004 mg/mg, 0.5 mg/mL, 1.5 mg/mL

, Liquid - Oral, Oral, Liquid, Solution, Solution - Oral, Tablet - Oral, Capsule, extended release, Capsule, extended release - Oral, Tablet, film coated - Oral, Tablet, Tablet, film coated, Powder, for solution, Capsule, liquid filled, Tablet, effervescent - Oral, Granule, effervescent - Oral, Granule, effervescent, Tablet, effervescent, Capsule, liquid filled - Oral, Powder, for solution - Oral, Suspension, Suspension - Oral, Capsule, Capsule - Oral, Tablet, coated - Oral, Tablet, coated, Tablet, extended release - Oral, Tablet, extended release, Syrup, Syrup - Oral, Suspension, extended release - Oral, Suspension, extended release, Kit, Tablet, film coated, extended release - Oral, Tablet, film coated, extended release, Capsule, gelatin coated, Capsule, gelatin coated - Oral, Powder, Tablet, sugar coated, Tablet, sugar coated - Oral, Granule, Granule - Oral, Powder - Oral, Tablet, multilayer - Oral, Tablet, multilayer, Lozenge, Lozenge - Oral, Tablet, chewable, Tablet, chewable - Oral, Capsule, delayed release pellets, Capsule, delayed release pellets - Oral, Granule, for solution, Granule, for solution - Oral, Liquid; Tablet - Oral; Parenteral, Oral; Parenteral, Liquid; Tablet, Liquid - Intramuscular; Intravenous; Subcutaneous, Intramuscular; Intravenous; Subcutaneous, Intramuscular; Oral; Subcutaneous, Liquid; Tablet - Intramuscular; Oral; Subcutaneous, Kit; Tablet - Oral, Kit; Tablet, Kit; Powder - Oral, Kit; Powder, Kit - Oral, Kit; Tablet; Tablet, extended release - Oral, Kit; Tablet; Tablet, extended release, Kit; Powder, for solution - Oral, Topical, Liquid - Topical, Kit; Powder, for solution, Solution / drops, Solution / drops - Oral, Solution / drops - Nasal, Tablet, multilayer, extended release, Tablet, multilayer, extended release - Oral, Nasal, Capsule, coated pellets, Capsule, coated pellets - Oral

Lacrimal Apparatus Diseases

, 1.0 mg/mL, 0.2 mg/mL, 2.0 mg, 4.0 mg, 8.0 mg, 2.0 mg/mL, 2.0 mL/mL, 4.0 mg/mL, 12.0 mg, 0.002 mg/mg, 0.0004 mg/mg, 0.75 mg/mL, 8.0 mg/mL, 9.0 mg, 1.995 mg/mL, 0.999 mg/mL, 1.001 mg/mL, 0.01 mg/mg, 0.03 mg/mg, 0.00025 mg/mg, 0.25 mg/mL, 0.6 mg/mL, 1.05 mg, 1.0 mg, 0.5 mg, 0.0125 mg/mg, 1.25 mg/mL, 0.667 mg, 4.5 mg/mL, 1.25 mg, 2.0 mg/mg, 0.002 mg, 24.0 mg, 0.4 mg/mL, 3.0 mg, 2.8 mg/mL, 3.5 mg, 0.001 mg/mg, 6.25 mg, 5.0 mg/mL, 0.1 mg/mL, 0.8 mg/mL, 5.0 mg, 4.5 mg, 10.0 mg/mL, 0.00087 mg/mg, 2.5 mg/mL, 0.004 mg/mg, 0.5 mg/mL, 1.5 mg/mL

, Liquid - Oral, Oral, Liquid, Solution, Solution - Oral, Tablet - Oral, Capsule, extended release, Capsule, extended release - Oral, Tablet, film coated - Oral, Tablet, Tablet, film coated, Powder, for solution, Capsule, liquid filled, Tablet, effervescent - Oral, Granule, effervescent - Oral, Granule, effervescent, Tablet, effervescent, Capsule, liquid filled - Oral, Powder, for solution - Oral, Suspension, Suspension - Oral, Capsule, Capsule - Oral, Tablet, coated - Oral, Tablet, coated, Tablet, extended release - Oral, Tablet, extended release, Syrup, Syrup - Oral, Suspension, extended release - Oral, Suspension, extended release, Kit, Tablet, film coated, extended release - Oral, Tablet, film coated, extended release, Capsule, gelatin coated, Capsule, gelatin coated - Oral, Powder, Tablet, sugar coated, Tablet, sugar coated - Oral, Granule, Granule - Oral, Powder - Oral, Tablet, multilayer - Oral, Tablet, multilayer, Lozenge, Lozenge - Oral, Tablet, chewable, Tablet, chewable - Oral, Capsule, delayed release pellets, Capsule, delayed release pellets - Oral, Granule, for solution, Granule, for solution - Oral, Liquid; Tablet - Oral; Parenteral, Oral; Parenteral, Liquid; Tablet, Liquid - Intramuscular; Intravenous; Subcutaneous, Intramuscular; Intravenous; Subcutaneous, Intramuscular; Oral; Subcutaneous, Liquid; Tablet - Intramuscular; Oral; Subcutaneous, Kit; Tablet - Oral, Kit; Tablet, Kit; Powder - Oral, Kit; Powder, Kit - Oral, Kit; Tablet; Tablet, extended release - Oral, Kit; Tablet; Tablet, extended release, Kit; Powder, for solution - Oral, Topical, Liquid - Topical, Kit; Powder, for solution, Solution / drops, Solution / drops - Oral, Solution / drops - Nasal, Tablet, multilayer, extended release, Tablet, multilayer, extended release - Oral, Nasal, Capsule, coated pellets, Capsule, coated pellets - Oral

Drug Allergy

, 1.0 mg/mL, 0.2 mg/mL, 2.0 mg, 4.0 mg, 8.0 mg, 2.0 mg/mL, 2.0 mL/mL, 4.0 mg/mL, 12.0 mg, 0.002 mg/mg, 0.0004 mg/mg, 0.75 mg/mL, 8.0 mg/mL, 9.0 mg, 1.995 mg/mL, 0.999 mg/mL, 1.001 mg/mL, 0.01 mg/mg, 0.03 mg/mg, 0.00025 mg/mg, 0.25 mg/mL, 0.6 mg/mL, 1.05 mg, 1.0 mg, 0.5 mg, 0.0125 mg/mg, 1.25 mg/mL, 0.667 mg, 4.5 mg/mL, 1.25 mg, 2.0 mg/mg, 0.002 mg, 24.0 mg, 0.4 mg/mL, 3.0 mg, 2.8 mg/mL, 3.5 mg, 0.001 mg/mg, 6.25 mg, 5.0 mg/mL, 0.1 mg/mL, 0.8 mg/mL, 5.0 mg, 4.5 mg, 10.0 mg/mL, 0.00087 mg/mg, 2.5 mg/mL, 0.004 mg/mg, 0.5 mg/mL, 1.5 mg/mL

, Liquid - Oral, Oral, Liquid, Solution, Solution - Oral, Tablet - Oral, Capsule, extended release, Capsule, extended release - Oral, Tablet, film coated - Oral, Tablet, Tablet, film coated, Powder, for solution, Capsule, liquid filled, Tablet, effervescent - Oral, Granule, effervescent - Oral, Granule, effervescent, Tablet, effervescent, Capsule, liquid filled - Oral, Powder, for solution - Oral, Suspension, Suspension - Oral, Capsule, Capsule - Oral, Tablet, coated - Oral, Tablet, coated, Tablet, extended release - Oral, Tablet, extended release, Syrup, Syrup - Oral, Suspension, extended release - Oral, Suspension, extended release, Kit, Tablet, film coated, extended release - Oral, Tablet, film coated, extended release, Capsule, gelatin coated, Capsule, gelatin coated - Oral, Powder, Tablet, sugar coated, Tablet, sugar coated - Oral, Granule, Granule - Oral, Powder - Oral, Tablet, multilayer - Oral, Tablet, multilayer, Lozenge, Lozenge - Oral, Tablet, chewable, Tablet, chewable - Oral, Capsule, delayed release pellets, Capsule, delayed release pellets - Oral, Granule, for solution, Granule, for solution - Oral, Liquid; Tablet - Oral; Parenteral, Oral; Parenteral, Liquid; Tablet, Liquid - Intramuscular; Intravenous; Subcutaneous, Intramuscular; Intravenous; Subcutaneous, Intramuscular; Oral; Subcutaneous, Liquid; Tablet - Intramuscular; Oral; Subcutaneous, Kit; Tablet - Oral, Kit; Tablet, Kit; Powder - Oral, Kit; Powder, Kit - Oral, Kit; Tablet; Tablet, extended release - Oral, Kit; Tablet; Tablet, extended release, Kit; Powder, for solution - Oral, Topical, Liquid - Topical, Kit; Powder, for solution, Solution / drops, Solution / drops - Oral, Solution / drops - Nasal, Tablet, multilayer, extended release, Tablet, multilayer, extended release - Oral, Nasal, Capsule, coated pellets, Capsule, coated pellets - Oral

Coughing

, 1.0 mg/mL, 0.2 mg/mL, 2.0 mg, 4.0 mg, 8.0 mg, 2.0 mg/mL, 2.0 mL/mL, 4.0 mg/mL, 12.0 mg, 0.002 mg/mg, 0.0004 mg/mg, 0.75 mg/mL, 8.0 mg/mL, 9.0 mg, 1.995 mg/mL, 0.999 mg/mL, 1.001 mg/mL, 0.01 mg/mg, 0.03 mg/mg, 0.00025 mg/mg, 0.25 mg/mL, 0.6 mg/mL, 1.05 mg, 1.0 mg, 0.5 mg, 0.0125 mg/mg, 1.25 mg/mL, 0.667 mg, 4.5 mg/mL, 1.25 mg, 2.0 mg/mg, 0.002 mg, 24.0 mg, 0.4 mg/mL, 3.0 mg, 2.8 mg/mL, 3.5 mg, 0.001 mg/mg, 6.25 mg, 5.0 mg/mL, 0.1 mg/mL, 0.8 mg/mL, 5.0 mg, 4.5 mg, 10.0 mg/mL, 0.00087 mg/mg, 2.5 mg/mL, 0.004 mg/mg, 0.5 mg/mL, 1.5 mg/mL

, Liquid - Oral, Oral, Liquid, Solution, Solution - Oral, Tablet - Oral, Capsule, extended release, Capsule, extended release - Oral, Tablet, film coated - Oral, Tablet, Tablet, film coated, Powder, for solution, Capsule, liquid filled, Tablet, effervescent - Oral, Granule, effervescent - Oral, Granule, effervescent, Tablet, effervescent, Capsule, liquid filled - Oral, Powder, for solution - Oral, Suspension, Suspension - Oral, Capsule, Capsule - Oral, Tablet, coated - Oral, Tablet, coated, Tablet, extended release - Oral, Tablet, extended release, Syrup, Syrup - Oral, Suspension, extended release - Oral, Suspension, extended release, Kit, Tablet, film coated, extended release - Oral, Tablet, film coated, extended release, Capsule, gelatin coated, Capsule, gelatin coated - Oral, Powder, Tablet, sugar coated, Tablet, sugar coated - Oral, Granule, Granule - Oral, Powder - Oral, Tablet, multilayer - Oral, Tablet, multilayer, Lozenge, Lozenge - Oral, Tablet, chewable, Tablet, chewable - Oral, Capsule, delayed release pellets, Capsule, delayed release pellets - Oral, Granule, for solution, Granule, for solution - Oral, Liquid; Tablet - Oral; Parenteral, Oral; Parenteral, Liquid; Tablet, Liquid - Intramuscular; Intravenous; Subcutaneous, Intramuscular; Intravenous; Subcutaneous, Intramuscular; Oral; Subcutaneous, Liquid; Tablet - Intramuscular; Oral; Subcutaneous, Kit; Tablet - Oral, Kit; Tablet, Kit; Powder - Oral, Kit; Powder, Kit - Oral, Kit; Tablet; Tablet, extended release - Oral, Kit; Tablet; Tablet, extended release, Kit; Powder, for solution - Oral, Topical, Liquid - Topical, Kit; Powder, for solution, Solution / drops, Solution / drops - Oral, Solution / drops - Nasal, Tablet, multilayer, extended release, Tablet, multilayer, extended release - Oral, Nasal, Capsule, coated pellets, Capsule, coated pellets - Oral

ocular hyperemia

, 1.0 mg/mL, 0.2 mg/mL, 2.0 mg, 4.0 mg, 8.0 mg, 2.0 mg/mL, 2.0 mL/mL, 4.0 mg/mL, 12.0 mg, 0.002 mg/mg, 0.0004 mg/mg, 0.75 mg/mL, 8.0 mg/mL, 9.0 mg, 1.995 mg/mL, 0.999 mg/mL, 1.001 mg/mL, 0.01 mg/mg, 0.03 mg/mg, 0.00025 mg/mg, 0.25 mg/mL, 0.6 mg/mL, 1.05 mg, 1.0 mg, 0.5 mg, 0.0125 mg/mg, 1.25 mg/mL, 0.667 mg, 4.5 mg/mL, 1.25 mg, 2.0 mg/mg, 0.002 mg, 24.0 mg, 0.4 mg/mL, 3.0 mg, 2.8 mg/mL, 3.5 mg, 0.001 mg/mg, 6.25 mg, 5.0 mg/mL, 0.1 mg/mL, 0.8 mg/mL, 5.0 mg, 4.5 mg, 10.0 mg/mL, 0.00087 mg/mg, 2.5 mg/mL, 0.004 mg/mg, 0.5 mg/mL, 1.5 mg/mL

, Liquid - Oral, Oral, Liquid, Solution, Solution - Oral, Tablet - Oral, Capsule, extended release, Capsule, extended release - Oral, Tablet, film coated - Oral, Tablet, Tablet, film coated, Powder, for solution, Capsule, liquid filled, Tablet, effervescent - Oral, Granule, effervescent - Oral, Granule, effervescent, Tablet, effervescent, Capsule, liquid filled - Oral, Powder, for solution - Oral, Suspension, Suspension - Oral, Capsule, Capsule - Oral, Tablet, coated - Oral, Tablet, coated, Tablet, extended release - Oral, Tablet, extended release, Syrup, Syrup - Oral, Suspension, extended release - Oral, Suspension, extended release, Kit, Tablet, film coated, extended release - Oral, Tablet, film coated, extended release, Capsule, gelatin coated, Capsule, gelatin coated - Oral, Powder, Tablet, sugar coated, Tablet, sugar coated - Oral, Granule, Granule - Oral, Powder - Oral, Tablet, multilayer - Oral, Tablet, multilayer, Lozenge, Lozenge - Oral, Tablet, chewable, Tablet, chewable - Oral, Capsule, delayed release pellets, Capsule, delayed release pellets - Oral, Granule, for solution, Granule, for solution - Oral, Liquid; Tablet - Oral; Parenteral, Oral; Parenteral, Liquid; Tablet, Liquid - Intramuscular; Intravenous; Subcutaneous, Intramuscular; Intravenous; Subcutaneous, Intramuscular; Oral; Subcutaneous, Liquid; Tablet - Intramuscular; Oral; Subcutaneous, Kit; Tablet - Oral, Kit; Tablet, Kit; Powder - Oral, Kit; Powder, Kit - Oral, Kit; Tablet; Tablet, extended release - Oral, Kit; Tablet; Tablet, extended release, Kit; Powder, for solution - Oral, Topical, Liquid - Topical, Kit; Powder, for solution, Solution / drops, Solution / drops - Oral, Solution / drops - Nasal, Tablet, multilayer, extended release, Tablet, multilayer, extended release - Oral, Nasal, Capsule, coated pellets, Capsule, coated pellets - Oral

Acute Bronchitis

, 1.0 mg/mL, 0.2 mg/mL, 2.0 mg, 4.0 mg, 8.0 mg, 2.0 mg/mL, 2.0 mL/mL, 4.0 mg/mL, 12.0 mg, 0.002 mg/mg, 0.0004 mg/mg, 0.75 mg/mL, 8.0 mg/mL, 9.0 mg, 1.995 mg/mL, 0.999 mg/mL, 1.001 mg/mL, 0.01 mg/mg, 0.03 mg/mg, 0.00025 mg/mg, 0.25 mg/mL, 0.6 mg/mL, 1.05 mg, 1.0 mg, 0.5 mg, 0.0125 mg/mg, 1.25 mg/mL, 0.667 mg, 4.5 mg/mL, 1.25 mg, 2.0 mg/mg, 0.002 mg, 24.0 mg, 0.4 mg/mL, 3.0 mg, 2.8 mg/mL, 3.5 mg, 0.001 mg/mg, 6.25 mg, 5.0 mg/mL, 0.1 mg/mL, 0.8 mg/mL, 5.0 mg, 4.5 mg, 10.0 mg/mL, 0.00087 mg/mg, 2.5 mg/mL, 0.004 mg/mg, 0.5 mg/mL, 1.5 mg/mL

, Liquid - Oral, Oral, Liquid, Solution, Solution - Oral, Tablet - Oral, Capsule, extended release, Capsule, extended release - Oral, Tablet, film coated - Oral, Tablet, Tablet, film coated, Powder, for solution, Capsule, liquid filled, Tablet, effervescent - Oral, Granule, effervescent - Oral, Granule, effervescent, Tablet, effervescent, Capsule, liquid filled - Oral, Powder, for solution - Oral, Suspension, Suspension - Oral, Capsule, Capsule - Oral, Tablet, coated - Oral, Tablet, coated, Tablet, extended release - Oral, Tablet, extended release, Syrup, Syrup - Oral, Suspension, extended release - Oral, Suspension, extended release, Kit, Tablet, film coated, extended release - Oral, Tablet, film coated, extended release, Capsule, gelatin coated, Capsule, gelatin coated - Oral, Powder, Tablet, sugar coated, Tablet, sugar coated - Oral, Granule, Granule - Oral, Powder - Oral, Tablet, multilayer - Oral, Tablet, multilayer, Lozenge, Lozenge - Oral, Tablet, chewable, Tablet, chewable - Oral, Capsule, delayed release pellets, Capsule, delayed release pellets - Oral, Granule, for solution, Granule, for solution - Oral, Liquid; Tablet - Oral; Parenteral, Oral; Parenteral, Liquid; Tablet, Liquid - Intramuscular; Intravenous; Subcutaneous, Intramuscular; Intravenous; Subcutaneous, Intramuscular; Oral; Subcutaneous, Liquid; Tablet - Intramuscular; Oral; Subcutaneous, Kit; Tablet - Oral, Kit; Tablet, Kit; Powder - Oral, Kit; Powder, Kit - Oral, Kit; Tablet; Tablet, extended release - Oral, Kit; Tablet; Tablet, extended release, Kit; Powder, for solution - Oral, Topical, Liquid - Topical, Kit; Powder, for solution, Solution / drops, Solution / drops - Oral, Solution / drops - Nasal, Tablet, multilayer, extended release, Tablet, multilayer, extended release - Oral, Nasal, Capsule, coated pellets, Capsule, coated pellets - Oral

Migraine

, 1.0 mg/mL, 0.2 mg/mL, 2.0 mg, 4.0 mg, 8.0 mg, 2.0 mg/mL, 2.0 mL/mL, 4.0 mg/mL, 12.0 mg, 0.002 mg/mg, 0.0004 mg/mg, 0.75 mg/mL, 8.0 mg/mL, 9.0 mg, 1.995 mg/mL, 0.999 mg/mL, 1.001 mg/mL, 0.01 mg/mg, 0.03 mg/mg, 0.00025 mg/mg, 0.25 mg/mL, 0.6 mg/mL, 1.05 mg, 1.0 mg, 0.5 mg, 0.0125 mg/mg, 1.25 mg/mL, 0.667 mg, 4.5 mg/mL, 1.25 mg, 2.0 mg/mg, 0.002 mg, 24.0 mg, 0.4 mg/mL, 3.0 mg, 2.8 mg/mL, 3.5 mg, 0.001 mg/mg, 6.25 mg, 5.0 mg/mL, 0.1 mg/mL, 0.8 mg/mL, 5.0 mg, 4.5 mg, 10.0 mg/mL, 0.00087 mg/mg, 2.5 mg/mL, 0.004 mg/mg, 0.5 mg/mL, 1.5 mg/mL

, Liquid - Oral, Oral, Liquid, Solution, Solution - Oral, Tablet - Oral, Capsule, extended release, Capsule, extended release - Oral, Tablet, film coated - Oral, Tablet, Tablet, film coated, Powder, for solution, Capsule, liquid filled, Tablet, effervescent - Oral, Granule, effervescent - Oral, Granule, effervescent, Tablet, effervescent, Capsule, liquid filled - Oral, Powder, for solution - Oral, Suspension, Suspension - Oral, Capsule, Capsule - Oral, Tablet, coated - Oral, Tablet, coated, Tablet, extended release - Oral, Tablet, extended release, Syrup, Syrup - Oral, Suspension, extended release - Oral, Suspension, extended release, Kit, Tablet, film coated, extended release - Oral, Tablet, film coated, extended release, Capsule, gelatin coated, Capsule, gelatin coated - Oral, Powder, Tablet, sugar coated, Tablet, sugar coated - Oral, Granule, Granule - Oral, Powder - Oral, Tablet, multilayer - Oral, Tablet, multilayer, Lozenge, Lozenge - Oral, Tablet, chewable, Tablet, chewable - Oral, Capsule, delayed release pellets, Capsule, delayed release pellets - Oral, Granule, for solution, Granule, for solution - Oral, Liquid; Tablet - Oral; Parenteral, Oral; Parenteral, Liquid; Tablet, Liquid - Intramuscular; Intravenous; Subcutaneous, Intramuscular; Intravenous; Subcutaneous, Intramuscular; Oral; Subcutaneous, Liquid; Tablet - Intramuscular; Oral; Subcutaneous, Kit; Tablet - Oral, Kit; Tablet, Kit; Powder - Oral, Kit; Powder, Kit - Oral, Kit; Tablet; Tablet, extended release - Oral, Kit; Tablet; Tablet, extended release, Kit; Powder, for solution - Oral, Topical, Liquid - Topical, Kit; Powder, for solution, Solution / drops, Solution / drops - Oral, Solution / drops - Nasal, Tablet, multilayer, extended release, Tablet, multilayer, extended release - Oral, Nasal, Capsule, coated pellets, Capsule, coated pellets - Oral

Pink Eye

, 1.0 mg/mL, 0.2 mg/mL, 2.0 mg, 4.0 mg, 8.0 mg, 2.0 mg/mL, 2.0 mL/mL, 4.0 mg/mL, 12.0 mg, 0.002 mg/mg, 0.0004 mg/mg, 0.75 mg/mL, 8.0 mg/mL, 9.0 mg, 1.995 mg/mL, 0.999 mg/mL, 1.001 mg/mL, 0.01 mg/mg, 0.03 mg/mg, 0.00025 mg/mg, 0.25 mg/mL, 0.6 mg/mL, 1.05 mg, 1.0 mg, 0.5 mg, 0.0125 mg/mg, 1.25 mg/mL, 0.667 mg, 4.5 mg/mL, 1.25 mg, 2.0 mg/mg, 0.002 mg, 24.0 mg, 0.4 mg/mL, 3.0 mg, 2.8 mg/mL, 3.5 mg, 0.001 mg/mg, 6.25 mg, 5.0 mg/mL, 0.1 mg/mL, 0.8 mg/mL, 5.0 mg, 4.5 mg, 10.0 mg/mL, 0.00087 mg/mg, 2.5 mg/mL, 0.004 mg/mg, 0.5 mg/mL, 1.5 mg/mL

, Liquid - Oral, Oral, Liquid, Solution, Solution - Oral, Tablet - Oral, Capsule, extended release, Capsule, extended release - Oral, Tablet, film coated - Oral, Tablet, Tablet, film coated, Powder, for solution, Capsule, liquid filled, Tablet, effervescent - Oral, Granule, effervescent - Oral, Granule, effervescent, Tablet, effervescent, Capsule, liquid filled - Oral, Powder, for solution - Oral, Suspension, Suspension - Oral, Capsule, Capsule - Oral, Tablet, coated - Oral, Tablet, coated, Tablet, extended release - Oral, Tablet, extended release, Syrup, Syrup - Oral, Suspension, extended release - Oral, Suspension, extended release, Kit, Tablet, film coated, extended release - Oral, Tablet, film coated, extended release, Capsule, gelatin coated, Capsule, gelatin coated - Oral, Powder, Tablet, sugar coated, Tablet, sugar coated - Oral, Granule, Granule - Oral, Powder - Oral, Tablet, multilayer - Oral, Tablet, multilayer, Lozenge, Lozenge - Oral, Tablet, chewable, Tablet, chewable - Oral, Capsule, delayed release pellets, Capsule, delayed release pellets - Oral, Granule, for solution, Granule, for solution - Oral, Liquid; Tablet - Oral; Parenteral, Oral; Parenteral, Liquid; Tablet, Liquid - Intramuscular; Intravenous; Subcutaneous, Intramuscular; Intravenous; Subcutaneous, Intramuscular; Oral; Subcutaneous, Liquid; Tablet - Intramuscular; Oral; Subcutaneous, Kit; Tablet - Oral, Kit; Tablet, Kit; Powder - Oral, Kit; Powder, Kit - Oral, Kit; Tablet; Tablet, extended release - Oral, Kit; Tablet; Tablet, extended release, Kit; Powder, for solution - Oral, Topical, Liquid - Topical, Kit; Powder, for solution, Solution / drops, Solution / drops - Oral, Solution / drops - Nasal, Tablet, multilayer, extended release, Tablet, multilayer, extended release - Oral, Nasal, Capsule, coated pellets, Capsule, coated pellets - Oral

Asthma

, 1.0 mg/mL, 0.2 mg/mL, 2.0 mg, 4.0 mg, 8.0 mg, 2.0 mg/mL, 2.0 mL/mL, 4.0 mg/mL, 12.0 mg, 0.002 mg/mg, 0.0004 mg/mg, 0.75 mg/mL, 8.0 mg/mL, 9.0 mg, 1.995 mg/mL, 0.999 mg/mL, 1.001 mg/mL, 0.01 mg/mg, 0.03 mg/mg, 0.00025 mg/mg, 0.25 mg/mL, 0.6 mg/mL, 1.05 mg, 1.0 mg, 0.5 mg, 0.0125 mg/mg, 1.25 mg/mL, 0.667 mg, 4.5 mg/mL, 1.25 mg, 2.0 mg/mg, 0.002 mg, 24.0 mg, 0.4 mg/mL, 3.0 mg, 2.8 mg/mL, 3.5 mg, 0.001 mg/mg, 6.25 mg, 5.0 mg/mL, 0.1 mg/mL, 0.8 mg/mL, 5.0 mg, 4.5 mg, 10.0 mg/mL, 0.00087 mg/mg, 2.5 mg/mL, 0.004 mg/mg, 0.5 mg/mL, 1.5 mg/mL

, Liquid - Oral, Oral, Liquid, Solution, Solution - Oral, Tablet - Oral, Capsule, extended release, Capsule, extended release - Oral, Tablet, film coated - Oral, Tablet, Tablet, film coated, Powder, for solution, Capsule, liquid filled, Tablet, effervescent - Oral, Granule, effervescent - Oral, Granule, effervescent, Tablet, effervescent, Capsule, liquid filled - Oral, Powder, for solution - Oral, Suspension, Suspension - Oral, Capsule, Capsule - Oral, Tablet, coated - Oral, Tablet, coated, Tablet, extended release - Oral, Tablet, extended release, Syrup, Syrup - Oral, Suspension, extended release - Oral, Suspension, extended release, Kit, Tablet, film coated, extended release - Oral, Tablet, film coated, extended release, Capsule, gelatin coated, Capsule, gelatin coated - Oral, Powder, Tablet, sugar coated, Tablet, sugar coated - Oral, Granule, Granule - Oral, Powder - Oral, Tablet, multilayer - Oral, Tablet, multilayer, Lozenge, Lozenge - Oral, Tablet, chewable, Tablet, chewable - Oral, Capsule, delayed release pellets, Capsule, delayed release pellets - Oral, Granule, for solution, Granule, for solution - Oral, Liquid; Tablet - Oral; Parenteral, Oral; Parenteral, Liquid; Tablet, Liquid - Intramuscular; Intravenous; Subcutaneous, Intramuscular; Intravenous; Subcutaneous, Intramuscular; Oral; Subcutaneous, Liquid; Tablet - Intramuscular; Oral; Subcutaneous, Kit; Tablet - Oral, Kit; Tablet, Kit; Powder - Oral, Kit; Powder, Kit - Oral, Kit; Tablet; Tablet, extended release - Oral, Kit; Tablet; Tablet, extended release, Kit; Powder, for solution - Oral, Topical, Liquid - Topical, Kit; Powder, for solution, Solution / drops, Solution / drops - Oral, Solution / drops - Nasal, Tablet, multilayer, extended release, Tablet, multilayer, extended release - Oral, Nasal, Capsule, coated pellets, Capsule, coated pellets - Oral

upper respiratory symptoms

, 1.0 mg/mL, 0.2 mg/mL, 2.0 mg, 4.0 mg, 8.0 mg, 2.0 mg/mL, 2.0 mL/mL, 4.0 mg/mL, 12.0 mg, 0.002 mg/mg, 0.0004 mg/mg, 0.75 mg/mL, 8.0 mg/mL, 9.0 mg, 1.995 mg/mL, 0.999 mg/mL, 1.001 mg/mL, 0.01 mg/mg, 0.03 mg/mg, 0.00025 mg/mg, 0.25 mg/mL, 0.6 mg/mL, 1.05 mg, 1.0 mg, 0.5 mg, 0.0125 mg/mg, 1.25 mg/mL, 0.667 mg, 4.5 mg/mL, 1.25 mg, 2.0 mg/mg, 0.002 mg, 24.0 mg, 0.4 mg/mL, 3.0 mg, 2.8 mg/mL, 3.5 mg, 0.001 mg/mg, 6.25 mg, 5.0 mg/mL, 0.1 mg/mL, 0.8 mg/mL, 5.0 mg, 4.5 mg, 10.0 mg/mL, 0.00087 mg/mg, 2.5 mg/mL, 0.004 mg/mg, 0.5 mg/mL, 1.5 mg/mL

, Liquid - Oral, Oral, Liquid, Solution, Solution - Oral, Tablet - Oral, Capsule, extended release, Capsule, extended release - Oral, Tablet, film coated - Oral, Tablet, Tablet, film coated, Powder, for solution, Capsule, liquid filled, Tablet, effervescent - Oral, Granule, effervescent - Oral, Granule, effervescent, Tablet, effervescent, Capsule, liquid filled - Oral, Powder, for solution - Oral, Suspension, Suspension - Oral, Capsule, Capsule - Oral, Tablet, coated - Oral, Tablet, coated, Tablet, extended release - Oral, Tablet, extended release, Syrup, Syrup - Oral, Suspension, extended release - Oral, Suspension, extended release, Kit, Tablet, film coated, extended release - Oral, Tablet, film coated, extended release, Capsule, gelatin coated, Capsule, gelatin coated - Oral, Powder, Tablet, sugar coated, Tablet, sugar coated - Oral, Granule, Granule - Oral, Powder - Oral, Tablet, multilayer - Oral, Tablet, multilayer, Lozenge, Lozenge - Oral, Tablet, chewable, Tablet, chewable - Oral, Capsule, delayed release pellets, Capsule, delayed release pellets - Oral, Granule, for solution, Granule, for solution - Oral, Liquid; Tablet - Oral; Parenteral, Oral; Parenteral, Liquid; Tablet, Liquid - Intramuscular; Intravenous; Subcutaneous, Intramuscular; Intravenous; Subcutaneous, Intramuscular; Oral; Subcutaneous, Liquid; Tablet - Intramuscular; Oral; Subcutaneous, Kit; Tablet - Oral, Kit; Tablet, Kit; Powder - Oral, Kit; Powder, Kit - Oral, Kit; Tablet; Tablet, extended release - Oral, Kit; Tablet; Tablet, extended release, Kit; Powder, for solution - Oral, Topical, Liquid - Topical, Kit; Powder, for solution, Solution / drops, Solution / drops - Oral, Solution / drops - Nasal, Tablet, multilayer, extended release, Tablet, multilayer, extended release - Oral, Nasal, Capsule, coated pellets, Capsule, coated pellets - Oral

Conjunctivitis

, 1.0 mg/mL, 0.2 mg/mL, 2.0 mg, 4.0 mg, 8.0 mg, 2.0 mg/mL, 2.0 mL/mL, 4.0 mg/mL, 12.0 mg, 0.002 mg/mg, 0.0004 mg/mg, 0.75 mg/mL, 8.0 mg/mL, 9.0 mg, 1.995 mg/mL, 0.999 mg/mL, 1.001 mg/mL, 0.01 mg/mg, 0.03 mg/mg, 0.00025 mg/mg, 0.25 mg/mL, 0.6 mg/mL, 1.05 mg, 1.0 mg, 0.5 mg, 0.0125 mg/mg, 1.25 mg/mL, 0.667 mg, 4.5 mg/mL, 1.25 mg, 2.0 mg/mg, 0.002 mg, 24.0 mg, 0.4 mg/mL, 3.0 mg, 2.8 mg/mL, 3.5 mg, 0.001 mg/mg, 6.25 mg, 5.0 mg/mL, 0.1 mg/mL, 0.8 mg/mL, 5.0 mg, 4.5 mg, 10.0 mg/mL, 0.00087 mg/mg, 2.5 mg/mL, 0.004 mg/mg, 0.5 mg/mL, 1.5 mg/mL

, Liquid - Oral, Oral, Liquid, Solution, Solution - Oral, Tablet - Oral, Capsule, extended release, Capsule, extended release - Oral, Tablet, film coated - Oral, Tablet, Tablet, film coated, Powder, for solution, Capsule, liquid filled, Tablet, effervescent - Oral, Granule, effervescent - Oral, Granule, effervescent, Tablet, effervescent, Capsule, liquid filled - Oral, Powder, for solution - Oral, Suspension, Suspension - Oral, Capsule, Capsule - Oral, Tablet, coated - Oral, Tablet, coated, Tablet, extended release - Oral, Tablet, extended release, Syrup, Syrup - Oral, Suspension, extended release - Oral, Suspension, extended release, Kit, Tablet, film coated, extended release - Oral, Tablet, film coated, extended release, Capsule, gelatin coated, Capsule, gelatin coated - Oral, Powder, Tablet, sugar coated, Tablet, sugar coated - Oral, Granule, Granule - Oral, Powder - Oral, Tablet, multilayer - Oral, Tablet, multilayer, Lozenge, Lozenge - Oral, Tablet, chewable, Tablet, chewable - Oral, Capsule, delayed release pellets, Capsule, delayed release pellets - Oral, Granule, for solution, Granule, for solution - Oral, Liquid; Tablet - Oral; Parenteral, Oral; Parenteral, Liquid; Tablet, Liquid - Intramuscular; Intravenous; Subcutaneous, Intramuscular; Intravenous; Subcutaneous, Intramuscular; Oral; Subcutaneous, Liquid; Tablet - Intramuscular; Oral; Subcutaneous, Kit; Tablet - Oral, Kit; Tablet, Kit; Powder - Oral, Kit; Powder, Kit - Oral, Kit; Tablet; Tablet, extended release - Oral, Kit; Tablet; Tablet, extended release, Kit; Powder, for solution - Oral, Topical, Liquid - Topical, Kit; Powder, for solution, Solution / drops, Solution / drops - Oral, Solution / drops - Nasal, Tablet, multilayer, extended release, Tablet, multilayer, extended release - Oral, Nasal, Capsule, coated pellets, Capsule, coated pellets - Oral

Upper respiratory tract congestion

, 1.0 mg/mL, 0.2 mg/mL, 2.0 mg, 4.0 mg, 8.0 mg, 2.0 mg/mL, 2.0 mL/mL, 4.0 mg/mL, 12.0 mg, 0.002 mg/mg, 0.0004 mg/mg, 0.75 mg/mL, 8.0 mg/mL, 9.0 mg, 1.995 mg/mL, 0.999 mg/mL, 1.001 mg/mL, 0.01 mg/mg, 0.03 mg/mg, 0.00025 mg/mg, 0.25 mg/mL, 0.6 mg/mL, 1.05 mg, 1.0 mg, 0.5 mg, 0.0125 mg/mg, 1.25 mg/mL, 0.667 mg, 4.5 mg/mL, 1.25 mg, 2.0 mg/mg, 0.002 mg, 24.0 mg, 0.4 mg/mL, 3.0 mg, 2.8 mg/mL, 3.5 mg, 0.001 mg/mg, 6.25 mg, 5.0 mg/mL, 0.1 mg/mL, 0.8 mg/mL, 5.0 mg, 4.5 mg, 10.0 mg/mL, 0.00087 mg/mg, 2.5 mg/mL, 0.004 mg/mg, 0.5 mg/mL, 1.5 mg/mL

, Liquid - Oral, Oral, Liquid, Solution, Solution - Oral, Tablet - Oral, Capsule, extended release, Capsule, extended release - Oral, Tablet, film coated - Oral, Tablet, Tablet, film coated, Powder, for solution, Capsule, liquid filled, Tablet, effervescent - Oral, Granule, effervescent - Oral, Granule, effervescent, Tablet, effervescent, Capsule, liquid filled - Oral, Powder, for solution - Oral, Suspension, Suspension - Oral, Capsule, Capsule - Oral, Tablet, coated - Oral, Tablet, coated, Tablet, extended release - Oral, Tablet, extended release, Syrup, Syrup - Oral, Suspension, extended release - Oral, Suspension, extended release, Kit, Tablet, film coated, extended release - Oral, Tablet, film coated, extended release, Capsule, gelatin coated, Capsule, gelatin coated - Oral, Powder, Tablet, sugar coated, Tablet, sugar coated - Oral, Granule, Granule - Oral, Powder - Oral, Tablet, multilayer - Oral, Tablet, multilayer, Lozenge, Lozenge - Oral, Tablet, chewable, Tablet, chewable - Oral, Capsule, delayed release pellets, Capsule, delayed release pellets - Oral, Granule, for solution, Granule, for solution - Oral, Liquid; Tablet - Oral; Parenteral, Oral; Parenteral, Liquid; Tablet, Liquid - Intramuscular; Intravenous; Subcutaneous, Intramuscular; Intravenous; Subcutaneous, Intramuscular; Oral; Subcutaneous, Liquid; Tablet - Intramuscular; Oral; Subcutaneous, Kit; Tablet - Oral, Kit; Tablet, Kit; Powder - Oral, Kit; Powder, Kit - Oral, Kit; Tablet; Tablet, extended release - Oral, Kit; Tablet; Tablet, extended release, Kit; Powder, for solution - Oral, Topical, Liquid - Topical, Kit; Powder, for solution, Solution / drops, Solution / drops - Oral, Solution / drops - Nasal, Tablet, multilayer, extended release, Tablet, multilayer, extended release - Oral, Nasal, Capsule, coated pellets, Capsule, coated pellets - Oral

Productive cough

, 1.0 mg/mL, 0.2 mg/mL, 2.0 mg, 4.0 mg, 8.0 mg, 2.0 mg/mL, 2.0 mL/mL, 4.0 mg/mL, 12.0 mg, 0.002 mg/mg, 0.0004 mg/mg, 0.75 mg/mL, 8.0 mg/mL, 9.0 mg, 1.995 mg/mL, 0.999 mg/mL, 1.001 mg/mL, 0.01 mg/mg, 0.03 mg/mg, 0.00025 mg/mg, 0.25 mg/mL, 0.6 mg/mL, 1.05 mg, 1.0 mg, 0.5 mg, 0.0125 mg/mg, 1.25 mg/mL, 0.667 mg, 4.5 mg/mL, 1.25 mg, 2.0 mg/mg, 0.002 mg, 24.0 mg, 0.4 mg/mL, 3.0 mg, 2.8 mg/mL, 3.5 mg, 0.001 mg/mg, 6.25 mg, 5.0 mg/mL, 0.1 mg/mL, 0.8 mg/mL, 5.0 mg, 4.5 mg, 10.0 mg/mL, 0.00087 mg/mg, 2.5 mg/mL, 0.004 mg/mg, 0.5 mg/mL, 1.5 mg/mL

, Liquid - Oral, Oral, Liquid, Solution, Solution - Oral, Tablet - Oral, Capsule, extended release, Capsule, extended release - Oral, Tablet, film coated - Oral, Tablet, Tablet, film coated, Powder, for solution, Capsule, liquid filled, Tablet, effervescent - Oral, Granule, effervescent - Oral, Granule, effervescent, Tablet, effervescent, Capsule, liquid filled - Oral, Powder, for solution - Oral, Suspension, Suspension - Oral, Capsule, Capsule - Oral, Tablet, coated - Oral, Tablet, coated, Tablet, extended release - Oral, Tablet, extended release, Syrup, Syrup - Oral, Suspension, extended release - Oral, Suspension, extended release, Kit, Tablet, film coated, extended release - Oral, Tablet, film coated, extended release, Capsule, gelatin coated, Capsule, gelatin coated - Oral, Powder, Tablet, sugar coated, Tablet, sugar coated - Oral, Granule, Granule - Oral, Powder - Oral, Tablet, multilayer - Oral, Tablet, multilayer, Lozenge, Lozenge - Oral, Tablet, chewable, Tablet, chewable - Oral, Capsule, delayed release pellets, Capsule, delayed release pellets - Oral, Granule, for solution, Granule, for solution - Oral, Liquid; Tablet - Oral; Parenteral, Oral; Parenteral, Liquid; Tablet, Liquid - Intramuscular; Intravenous; Subcutaneous, Intramuscular; Intravenous; Subcutaneous, Intramuscular; Oral; Subcutaneous, Liquid; Tablet - Intramuscular; Oral; Subcutaneous, Kit; Tablet - Oral, Kit; Tablet, Kit; Powder - Oral, Kit; Powder, Kit - Oral, Kit; Tablet; Tablet, extended release - Oral, Kit; Tablet; Tablet, extended release, Kit; Powder, for solution - Oral, Topical, Liquid - Topical, Kit; Powder, for solution, Solution / drops, Solution / drops - Oral, Solution / drops - Nasal, Tablet, multilayer, extended release, Tablet, multilayer, extended release - Oral, Nasal, Capsule, coated pellets, Capsule, coated pellets - Oral

Rhinorrhea

, 1.0 mg/mL, 0.2 mg/mL, 2.0 mg, 4.0 mg, 8.0 mg, 2.0 mg/mL, 2.0 mL/mL, 4.0 mg/mL, 12.0 mg, 0.002 mg/mg, 0.0004 mg/mg, 0.75 mg/mL, 8.0 mg/mL, 9.0 mg, 1.995 mg/mL, 0.999 mg/mL, 1.001 mg/mL, 0.01 mg/mg, 0.03 mg/mg, 0.00025 mg/mg, 0.25 mg/mL, 0.6 mg/mL, 1.05 mg, 1.0 mg, 0.5 mg, 0.0125 mg/mg, 1.25 mg/mL, 0.667 mg, 4.5 mg/mL, 1.25 mg, 2.0 mg/mg, 0.002 mg, 24.0 mg, 0.4 mg/mL, 3.0 mg, 2.8 mg/mL, 3.5 mg, 0.001 mg/mg, 6.25 mg, 5.0 mg/mL, 0.1 mg/mL, 0.8 mg/mL, 5.0 mg, 4.5 mg, 10.0 mg/mL, 0.00087 mg/mg, 2.5 mg/mL, 0.004 mg/mg, 0.5 mg/mL, 1.5 mg/mL

, Liquid - Oral, Oral, Liquid, Solution, Solution - Oral, Tablet - Oral, Capsule, extended release, Capsule, extended release - Oral, Tablet, film coated - Oral, Tablet, Tablet, film coated, Powder, for solution, Capsule, liquid filled, Tablet, effervescent - Oral, Granule, effervescent - Oral, Granule, effervescent, Tablet, effervescent, Capsule, liquid filled - Oral, Powder, for solution - Oral, Suspension, Suspension - Oral, Capsule, Capsule - Oral, Tablet, coated - Oral, Tablet, coated, Tablet, extended release - Oral, Tablet, extended release, Syrup, Syrup - Oral, Suspension, extended release - Oral, Suspension, extended release, Kit, Tablet, film coated, extended release - Oral, Tablet, film coated, extended release, Capsule, gelatin coated, Capsule, gelatin coated - Oral, Powder, Tablet, sugar coated, Tablet, sugar coated - Oral, Granule, Granule - Oral, Powder - Oral, Tablet, multilayer - Oral, Tablet, multilayer, Lozenge, Lozenge - Oral, Tablet, chewable, Tablet, chewable - Oral, Capsule, delayed release pellets, Capsule, delayed release pellets - Oral, Granule, for solution, Granule, for solution - Oral, Liquid; Tablet - Oral; Parenteral, Oral; Parenteral, Liquid; Tablet, Liquid - Intramuscular; Intravenous; Subcutaneous, Intramuscular; Intravenous; Subcutaneous, Intramuscular; Oral; Subcutaneous, Liquid; Tablet - Intramuscular; Oral; Subcutaneous, Kit; Tablet - Oral, Kit; Tablet, Kit; Powder - Oral, Kit; Powder, Kit - Oral, Kit; Tablet; Tablet, extended release - Oral, Kit; Tablet; Tablet, extended release, Kit; Powder, for solution - Oral, Topical, Liquid - Topical, Kit; Powder, for solution, Solution / drops, Solution / drops - Oral, Solution / drops - Nasal, Tablet, multilayer, extended release, Tablet, multilayer, extended release - Oral, Nasal, Capsule, coated pellets, Capsule, coated pellets - Oral

Cold

, 1.0 mg/mL, 0.2 mg/mL, 2.0 mg, 4.0 mg, 8.0 mg, 2.0 mg/mL, 2.0 mL/mL, 4.0 mg/mL, 12.0 mg, 0.002 mg/mg, 0.0004 mg/mg, 0.75 mg/mL, 8.0 mg/mL, 9.0 mg, 1.995 mg/mL, 0.999 mg/mL, 1.001 mg/mL, 0.01 mg/mg, 0.03 mg/mg, 0.00025 mg/mg, 0.25 mg/mL, 0.6 mg/mL, 1.05 mg, 1.0 mg, 0.5 mg, 0.0125 mg/mg, 1.25 mg/mL, 0.667 mg, 4.5 mg/mL, 1.25 mg, 2.0 mg/mg, 0.002 mg, 24.0 mg, 0.4 mg/mL, 3.0 mg, 2.8 mg/mL, 3.5 mg, 0.001 mg/mg, 6.25 mg, 5.0 mg/mL, 0.1 mg/mL, 0.8 mg/mL, 5.0 mg, 4.5 mg, 10.0 mg/mL, 0.00087 mg/mg, 2.5 mg/mL, 0.004 mg/mg, 0.5 mg/mL, 1.5 mg/mL

, Liquid - Oral, Oral, Liquid, Solution, Solution - Oral, Tablet - Oral, Capsule, extended release, Capsule, extended release - Oral, Tablet, film coated - Oral, Tablet, Tablet, film coated, Powder, for solution, Capsule, liquid filled, Tablet, effervescent - Oral, Granule, effervescent - Oral, Granule, effervescent, Tablet, effervescent, Capsule, liquid filled - Oral, Powder, for solution - Oral, Suspension, Suspension - Oral, Capsule, Capsule - Oral, Tablet, coated - Oral, Tablet, coated, Tablet, extended release - Oral, Tablet, extended release, Syrup, Syrup - Oral, Suspension, extended release - Oral, Suspension, extended release, Kit, Tablet, film coated, extended release - Oral, Tablet, film coated, extended release, Capsule, gelatin coated, Capsule, gelatin coated - Oral, Powder, Tablet, sugar coated, Tablet, sugar coated - Oral, Granule, Granule - Oral, Powder - Oral, Tablet, multilayer - Oral, Tablet, multilayer, Lozenge, Lozenge - Oral, Tablet, chewable, Tablet, chewable - Oral, Capsule, delayed release pellets, Capsule, delayed release pellets - Oral, Granule, for solution, Granule, for solution - Oral, Liquid; Tablet - Oral; Parenteral, Oral; Parenteral, Liquid; Tablet, Liquid - Intramuscular; Intravenous; Subcutaneous, Intramuscular; Intravenous; Subcutaneous, Intramuscular; Oral; Subcutaneous, Liquid; Tablet - Intramuscular; Oral; Subcutaneous, Kit; Tablet - Oral, Kit; Tablet, Kit; Powder - Oral, Kit; Powder, Kit - Oral, Kit; Tablet; Tablet, extended release - Oral, Kit; Tablet; Tablet, extended release, Kit; Powder, for solution - Oral, Topical, Liquid - Topical, Kit; Powder, for solution, Solution / drops, Solution / drops - Oral, Solution / drops - Nasal, Tablet, multilayer, extended release, Tablet, multilayer, extended release - Oral, Nasal, Capsule, coated pellets, Capsule, coated pellets - Oral

House Dust Mite Allergy

, 1.0 mg/mL, 0.2 mg/mL, 2.0 mg, 4.0 mg, 8.0 mg, 2.0 mg/mL, 2.0 mL/mL, 4.0 mg/mL, 12.0 mg, 0.002 mg/mg, 0.0004 mg/mg, 0.75 mg/mL, 8.0 mg/mL, 9.0 mg, 1.995 mg/mL, 0.999 mg/mL, 1.001 mg/mL, 0.01 mg/mg, 0.03 mg/mg, 0.00025 mg/mg, 0.25 mg/mL, 0.6 mg/mL, 1.05 mg, 1.0 mg, 0.5 mg, 0.0125 mg/mg, 1.25 mg/mL, 0.667 mg, 4.5 mg/mL, 1.25 mg, 2.0 mg/mg, 0.002 mg, 24.0 mg, 0.4 mg/mL, 3.0 mg, 2.8 mg/mL, 3.5 mg, 0.001 mg/mg, 6.25 mg, 5.0 mg/mL, 0.1 mg/mL, 0.8 mg/mL, 5.0 mg, 4.5 mg, 10.0 mg/mL, 0.00087 mg/mg, 2.5 mg/mL, 0.004 mg/mg, 0.5 mg/mL, 1.5 mg/mL

, Liquid - Oral, Oral, Liquid, Solution, Solution - Oral, Tablet - Oral, Capsule, extended release, Capsule, extended release - Oral, Tablet, film coated - Oral, Tablet, Tablet, film coated, Powder, for solution, Capsule, liquid filled, Tablet, effervescent - Oral, Granule, effervescent - Oral, Granule, effervescent, Tablet, effervescent, Capsule, liquid filled - Oral, Powder, for solution - Oral, Suspension, Suspension - Oral, Capsule, Capsule - Oral, Tablet, coated - Oral, Tablet, coated, Tablet, extended release - Oral, Tablet, extended release, Syrup, Syrup - Oral, Suspension, extended release - Oral, Suspension, extended release, Kit, Tablet, film coated, extended release - Oral, Tablet, film coated, extended release, Capsule, gelatin coated, Capsule, gelatin coated - Oral, Powder, Tablet, sugar coated, Tablet, sugar coated - Oral, Granule, Granule - Oral, Powder - Oral, Tablet, multilayer - Oral, Tablet, multilayer, Lozenge, Lozenge - Oral, Tablet, chewable, Tablet, chewable - Oral, Capsule, delayed release pellets, Capsule, delayed release pellets - Oral, Granule, for solution, Granule, for solution - Oral, Liquid; Tablet - Oral; Parenteral, Oral; Parenteral, Liquid; Tablet, Liquid - Intramuscular; Intravenous; Subcutaneous, Intramuscular; Intravenous; Subcutaneous, Intramuscular; Oral; Subcutaneous, Liquid; Tablet - Intramuscular; Oral; Subcutaneous, Kit; Tablet - Oral, Kit; Tablet, Kit; Powder - Oral, Kit; Powder, Kit - Oral, Kit; Tablet; Tablet, extended release - Oral, Kit; Tablet; Tablet, extended release, Kit; Powder, for solution - Oral, Topical, Liquid - Topical, Kit; Powder, for solution, Solution / drops, Solution / drops - Oral, Solution / drops - Nasal, Tablet, multilayer, extended release, Tablet, multilayer, extended release - Oral, Nasal, Capsule, coated pellets, Capsule, coated pellets - Oral

Asthma

, 1.0 mg/mL, 0.2 mg/mL, 2.0 mg, 4.0 mg, 8.0 mg, 2.0 mg/mL, 2.0 mL/mL, 4.0 mg/mL, 12.0 mg, 0.002 mg/mg, 0.0004 mg/mg, 0.75 mg/mL, 8.0 mg/mL, 9.0 mg, 1.995 mg/mL, 0.999 mg/mL, 1.001 mg/mL, 0.01 mg/mg, 0.03 mg/mg, 0.00025 mg/mg, 0.25 mg/mL, 0.6 mg/mL, 1.05 mg, 1.0 mg, 0.5 mg, 0.0125 mg/mg, 1.25 mg/mL, 0.667 mg, 4.5 mg/mL, 1.25 mg, 2.0 mg/mg, 0.002 mg, 24.0 mg, 0.4 mg/mL, 3.0 mg, 2.8 mg/mL, 3.5 mg, 0.001 mg/mg, 6.25 mg, 5.0 mg/mL, 0.1 mg/mL, 0.8 mg/mL, 5.0 mg, 4.5 mg, 10.0 mg/mL, 0.00087 mg/mg, 2.5 mg/mL, 0.004 mg/mg, 0.5 mg/mL, 1.5 mg/mL

, Liquid - Oral, Oral, Liquid, Solution, Solution - Oral, Tablet - Oral, Capsule, extended release, Capsule, extended release - Oral, Tablet, film coated - Oral, Tablet, Tablet, film coated, Powder, for solution, Capsule, liquid filled, Tablet, effervescent - Oral, Granule, effervescent - Oral, Granule, effervescent, Tablet, effervescent, Capsule, liquid filled - Oral, Powder, for solution - Oral, Suspension, Suspension - Oral, Capsule, Capsule - Oral, Tablet, coated - Oral, Tablet, coated, Tablet, extended release - Oral, Tablet, extended release, Syrup, Syrup - Oral, Suspension, extended release - Oral, Suspension, extended release, Kit, Tablet, film coated, extended release - Oral, Tablet, film coated, extended release, Capsule, gelatin coated, Capsule, gelatin coated - Oral, Powder, Tablet, sugar coated, Tablet, sugar coated - Oral, Granule, Granule - Oral, Powder - Oral, Tablet, multilayer - Oral, Tablet, multilayer, Lozenge, Lozenge - Oral, Tablet, chewable, Tablet, chewable - Oral, Capsule, delayed release pellets, Capsule, delayed release pellets - Oral, Granule, for solution, Granule, for solution - Oral, Liquid; Tablet - Oral; Parenteral, Oral; Parenteral, Liquid; Tablet, Liquid - Intramuscular; Intravenous; Subcutaneous, Intramuscular; Intravenous; Subcutaneous, Intramuscular; Oral; Subcutaneous, Liquid; Tablet - Intramuscular; Oral; Subcutaneous, Kit; Tablet - Oral, Kit; Tablet, Kit; Powder - Oral, Kit; Powder, Kit - Oral, Kit; Tablet; Tablet, extended release - Oral, Kit; Tablet; Tablet, extended release, Kit; Powder, for solution - Oral, Topical, Liquid - Topical, Kit; Powder, for solution, Solution / drops, Solution / drops - Oral, Solution / drops - Nasal, Tablet, multilayer, extended release, Tablet, multilayer, extended release - Oral, Nasal, Capsule, coated pellets, Capsule, coated pellets - Oral

Dermatitis, Allergic Contact

, 1.0 mg/mL, 0.2 mg/mL, 2.0 mg, 4.0 mg, 8.0 mg, 2.0 mg/mL, 2.0 mL/mL, 4.0 mg/mL, 12.0 mg, 0.002 mg/mg, 0.0004 mg/mg, 0.75 mg/mL, 8.0 mg/mL, 9.0 mg, 1.995 mg/mL, 0.999 mg/mL, 1.001 mg/mL, 0.01 mg/mg, 0.03 mg/mg, 0.00025 mg/mg, 0.25 mg/mL, 0.6 mg/mL, 1.05 mg, 1.0 mg, 0.5 mg, 0.0125 mg/mg, 1.25 mg/mL, 0.667 mg, 4.5 mg/mL, 1.25 mg, 2.0 mg/mg, 0.002 mg, 24.0 mg, 0.4 mg/mL, 3.0 mg, 2.8 mg/mL, 3.5 mg, 0.001 mg/mg, 6.25 mg, 5.0 mg/mL, 0.1 mg/mL, 0.8 mg/mL, 5.0 mg, 4.5 mg, 10.0 mg/mL, 0.00087 mg/mg, 2.5 mg/mL, 0.004 mg/mg, 0.5 mg/mL, 1.5 mg/mL

, Liquid - Oral, Oral, Liquid, Solution, Solution - Oral, Tablet - Oral, Capsule, extended release, Capsule, extended release - Oral, Tablet, film coated - Oral, Tablet, Tablet, film coated, Powder, for solution, Capsule, liquid filled, Tablet, effervescent - Oral, Granule, effervescent - Oral, Granule, effervescent, Tablet, effervescent, Capsule, liquid filled - Oral, Powder, for solution - Oral, Suspension, Suspension - Oral, Capsule, Capsule - Oral, Tablet, coated - Oral, Tablet, coated, Tablet, extended release - Oral, Tablet, extended release, Syrup, Syrup - Oral, Suspension, extended release - Oral, Suspension, extended release, Kit, Tablet, film coated, extended release - Oral, Tablet, film coated, extended release, Capsule, gelatin coated, Capsule, gelatin coated - Oral, Powder, Tablet, sugar coated, Tablet, sugar coated - Oral, Granule, Granule - Oral, Powder - Oral, Tablet, multilayer - Oral, Tablet, multilayer, Lozenge, Lozenge - Oral, Tablet, chewable, Tablet, chewable - Oral, Capsule, delayed release pellets, Capsule, delayed release pellets - Oral, Granule, for solution, Granule, for solution - Oral, Liquid; Tablet - Oral; Parenteral, Oral; Parenteral, Liquid; Tablet, Liquid - Intramuscular; Intravenous; Subcutaneous, Intramuscular; Intravenous; Subcutaneous, Intramuscular; Oral; Subcutaneous, Liquid; Tablet - Intramuscular; Oral; Subcutaneous, Kit; Tablet - Oral, Kit; Tablet, Kit; Powder - Oral, Kit; Powder, Kit - Oral, Kit; Tablet; Tablet, extended release - Oral, Kit; Tablet; Tablet, extended release, Kit; Powder, for solution - Oral, Topical, Liquid - Topical, Kit; Powder, for solution, Solution / drops, Solution / drops - Oral, Solution / drops - Nasal, Tablet, multilayer, extended release, Tablet, multilayer, extended release - Oral, Nasal, Capsule, coated pellets, Capsule, coated pellets - Oral

Allergy to Tree Pollen

, 1.0 mg/mL, 0.2 mg/mL, 2.0 mg, 4.0 mg, 8.0 mg, 2.0 mg/mL, 2.0 mL/mL, 4.0 mg/mL, 12.0 mg, 0.002 mg/mg, 0.0004 mg/mg, 0.75 mg/mL, 8.0 mg/mL, 9.0 mg, 1.995 mg/mL, 0.999 mg/mL, 1.001 mg/mL, 0.01 mg/mg, 0.03 mg/mg, 0.00025 mg/mg, 0.25 mg/mL, 0.6 mg/mL, 1.05 mg, 1.0 mg, 0.5 mg, 0.0125 mg/mg, 1.25 mg/mL, 0.667 mg, 4.5 mg/mL, 1.25 mg, 2.0 mg/mg, 0.002 mg, 24.0 mg, 0.4 mg/mL, 3.0 mg, 2.8 mg/mL, 3.5 mg, 0.001 mg/mg, 6.25 mg, 5.0 mg/mL, 0.1 mg/mL, 0.8 mg/mL, 5.0 mg, 4.5 mg, 10.0 mg/mL, 0.00087 mg/mg, 2.5 mg/mL, 0.004 mg/mg, 0.5 mg/mL, 1.5 mg/mL

, Liquid - Oral, Oral, Liquid, Solution, Solution - Oral, Tablet - Oral, Capsule, extended release, Capsule, extended release - Oral, Tablet, film coated - Oral, Tablet, Tablet, film coated, Powder, for solution, Capsule, liquid filled, Tablet, effervescent - Oral, Granule, effervescent - Oral, Granule, effervescent, Tablet, effervescent, Capsule, liquid filled - Oral, Powder, for solution - Oral, Suspension, Suspension - Oral, Capsule, Capsule - Oral, Tablet, coated - Oral, Tablet, coated, Tablet, extended release - Oral, Tablet, extended release, Syrup, Syrup - Oral, Suspension, extended release - Oral, Suspension, extended release, Kit, Tablet, film coated, extended release - Oral, Tablet, film coated, extended release, Capsule, gelatin coated, Capsule, gelatin coated - Oral, Powder, Tablet, sugar coated, Tablet, sugar coated - Oral, Granule, Granule - Oral, Powder - Oral, Tablet, multilayer - Oral, Tablet, multilayer, Lozenge, Lozenge - Oral, Tablet, chewable, Tablet, chewable - Oral, Capsule, delayed release pellets, Capsule, delayed release pellets - Oral, Granule, for solution, Granule, for solution - Oral, Liquid; Tablet - Oral; Parenteral, Oral; Parenteral, Liquid; Tablet, Liquid - Intramuscular; Intravenous; Subcutaneous, Intramuscular; Intravenous; Subcutaneous, Intramuscular; Oral; Subcutaneous, Liquid; Tablet - Intramuscular; Oral; Subcutaneous, Kit; Tablet - Oral, Kit; Tablet, Kit; Powder - Oral, Kit; Powder, Kit - Oral, Kit; Tablet; Tablet, extended release - Oral, Kit; Tablet; Tablet, extended release, Kit; Powder, for solution - Oral, Topical, Liquid - Topical, Kit; Powder, for solution, Solution / drops, Solution / drops - Oral, Solution / drops - Nasal, Tablet, multilayer, extended release, Tablet, multilayer, extended release - Oral, Nasal, Capsule, coated pellets, Capsule, coated pellets - Oral

Warnings

Tussicaps has twenty-one restrictions. It should not be taken in combination with any of the circumstances detailed in the following table.

There are 20 known major drug interactions with Tussicaps.

Common Tussicaps Drug Interactions

Drug Name

Risk Level

Description

Amoxapine

Major

The metabolism of Amoxapine can be decreased when combined with Chlorpheniramine.

Anagrelide

Major

The risk or severity of QTc prolongation can be increased when Chlorpheniramine is combined with Anagrelide.

Arsenic trioxide

Major

The risk or severity of QTc prolongation can be increased when Chlorpheniramine is combined with Arsenic trioxide.

Artemether

Major

The risk or severity of QTc prolongation can be increased when Chlorpheniramine is combined with Artemether.

Asenapine

Major

The risk or severity of QTc prolongation can be increased when Chlorpheniramine is combined with Asenapine.

Tussicaps Toxicity & Overdose Risk

Taking too much hydrocodone can lead to serious symptoms such as breathing problems, sleepiness, lack of muscle movement, cold and clammy skin, small pupils, fluid in the lungs, slow heartbeat, low blood pressure, or even death. To respond to an overdose, a person must be given oxygen and possibly assisted ventilation. Other treatments may include IV fluids, oxygen, and medication to raise blood pressure. Emergency medical help should be called if the person experiences cardiac arrest or an irregular heartbeat. A medication called naloxone can be administered to reverse the effects of the overdose, but medical attention is still necessary as the effects of

image of a doctor in a lab doing drug, clinical research

Tussicaps Novel Uses: Which Conditions Have a Clinical Trial Featuring Tussicaps?

50 active clinical trials are currently being conducted to investigate the potential of Tussicaps to alleviate Chronic Pain, Nasal Congestion stemming from the Common Cold and Acute Bronchitis.

Condition

Clinical Trials

Trial Phases

Migraine

51 Actively Recruiting

Phase 4, Not Applicable, Phase 1, Phase 3, Phase 2, Early Phase 1

Asthma

87 Actively Recruiting

Phase 1, Phase 4, Early Phase 1, Not Applicable, Phase 2, Phase 3

Transfusion Reaction

0 Actively Recruiting

Pink Eye

0 Actively Recruiting

Nasal Congestion

0 Actively Recruiting

Hypersensitivity

1 Actively Recruiting

Phase 4

Headache

0 Actively Recruiting

ocular hyperemia

0 Actively Recruiting

Influenza

0 Actively Recruiting

Conjunctivitis

0 Actively Recruiting

Coughing

0 Actively Recruiting

Airway secretion clearance therapy

0 Actively Recruiting

Nose

0 Actively Recruiting

Allergy to vaccine

0 Actively Recruiting

Angioedema

0 Actively Recruiting

Rhinorrhea

0 Actively Recruiting

Seasonal Allergic Conjunctivitis

0 Actively Recruiting

Cold

0 Actively Recruiting

Lacrimal Apparatus Diseases

0 Actively Recruiting

Coughing

0 Actively Recruiting

Tussicaps Reviews: What are patients saying about Tussicaps?

5

Patient Review

12/27/2009

Tussicaps for Cough

I really liked this cough suppressant! I was hesitant to try a pill, but it worked great. No nasty taste or mess like with syrup, and it made me feel relaxed and happy without being too drowsy.

5

Patient Review

12/15/2009

Tussicaps for Cough

I was worried that, at $4 a pill, these wouldn't work. But I was amazed--they were awesome. After a month of suffering with a sinus and upper respiratory infection that wouldn't go away, this stopped the cough the others couldn't. My chest felt like i had been beaten up until i took them. All I can say is wow and thank you!

5

Patient Review

12/4/2009

Tussicaps for Cough

I would not recommend this medication to anyone. I had a terrible experience with it and suffered through restless nights, vomiting, dizziness, and headaches.

5

Patient Review

1/20/2010

Tussicaps for Cough

I was in a lot of pain from coughing for four days straight before I tried this treatment. Within just a few hours, the cough began to subside and within six hours it had almost completely stopped. And on top of that, the pain was gone too!

5

Patient Review

12/14/2010

Tussicaps for Cough

This is an effective treatment, and worth the price tag.

5

Patient Review

3/20/2010

Tussicaps for Cough

Though this treatment effectively got rid of my cough, the side effects were not worth it. I felt nauseous and dizzy for an entire day after just one dose.

5

Patient Review

1/13/2015

Tussicaps for Cough

Tussicaps, used in conjunction with an antibiotic, cleared up my respiratory infection and cough very effectively. I'm now able to go back to work without any issues.

5

Patient Review

10/29/2009

Tussicaps for Cough

5

Patient Review

4/28/2012

Tussicaps for Cold Symptoms

I had a severe reaction to this medication a few hours after taking only one capsule. I was administered Benedryl (maximum dose) three times during the day, and I'm still having some reactions 24 hours later, although they are not as severe. I contacted the company to determine which ingredient most likely caused this effect so that I can avoid it in the future. This has been very scary for me, with large welts that look almost like blisters, and are very red and itchy.

4.7

Patient Review

12/18/2009

Tussicaps for Cough

This medicine was very effective at suppressing my cough and stopping the burning pain in my chest. The drowsiness it caused was a bit of an issue, but since I was already out of work sick, it wasn't really a problem for me.

4.3

Patient Review

11/6/2009

Tussicaps for Cough

While this treatment didn't stop my coughing at all, it did help me get through the bronchitis a bit easier.

3.7

Patient Review

5/7/2011

Tussicaps for Cold Symptoms

Tussicaps are a great option for those with an upper respiratory issue. They work quickly and last for several hours. The only downside is that they can cause lightheadedness if taken on an empty stomach, but it's a small price to pay for the relief they provide.

3

Patient Review

1/6/2010

Tussicaps for Cough

I was never aware of this medication until my doctor prescribed it for me. It's been really helpful in reducing my cough reflex.

2.3

Patient Review

10/7/2009

Tussicaps for Cough

2.3

Patient Review

10/28/2009

Tussicaps for Cough

image of drug pills surrounding a glass of water symbolizing drug consumption

Patient Q&A Section about tussicaps

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

What is the drug tussionex?

"TUSSIONEX Pennkinetic Extended-Release Suspension is a prescription medicine used to treat cough and upper respiratory symptoms that you can have with allergies or a cold. TUSSIONEX Pennkinetic Extended-Release Suspension is for adults and children aged 6 years and older."

Answered by AI

What is Deconamine used for?

"Decongestants help to reduce swelling in the nasal passages.

This medication is a combination of an antihistamine and a decongestant and is used to relieve symptoms of the common cold, flu, allergies, or other breathing illnesses temporarily. Antihistamines help relieve watery eyes, itchy eyes/nose/throat, runny nose, and sneezing while decongestants help reduce swelling in the nasal passages."

Answered by AI

What are TussiCaps used for?

"- The FDA has approved TussiCaps (acetaminophen, dextromethorphan, guaifenesin, and phenylephrine) oral suspension, the first fixed-dose combination of these four drugs in a single product.

TussiCaps has been approved by the FDA to treat runny nose, sneezing, itching, watery eyes, and cough caused by allergies, the common cold, or the flu. This is the first fixed-dose combination of these four drugs in a single product."

Answered by AI

Clinical Trials for Tussicaps

Image of Johns Hopkins Bayview Medical Center in Baltimore, United States.

VR-Enhanced PMR for Post-Burn Symptoms

18+
All Sexes
Baltimore, MD

The goal of this clinical trial is to learn whether progressive muscle relaxation (PMR), delivered either alone or enhanced with virtual reality (VR), can help treat chronic symptom, such as pain, itch, anxiety, sleep disturbances, and fatigue, in adult burn survivors. The main questions it aims to answer are: * Does VR-enhanced PMR (VR-PMR) reduce chronic pain, anxiety, itch, sleep disturbances, and fatigue more effectively than standard PMR? * Is VR-PMR a feasible and acceptable self-administered home-based intervention for burn survivors? Researchers will compare two self-administered intervention conditions, VR-enhanced PMR and standard PMR, using a randomized to sequence crossover design to see if VR technology enhances the therapeutic effects of PMR on chronic symptom management in burn survivors. Participants will: * Complete home-based sessions of VR-enhanced PMR * Complete home-based sessions of standard PMR * Report symptoms such as pain, itch, anxiety, sleep disturbances, and fatigue throughout the study * Use VR equipment provided for the intervention period (during the VR-PMR arm)

Recruiting
Has No Placebo

Johns Hopkins Bayview Medical Center

Sheera Lerman Zohar, PhD

Image of Cedars-Sinai Medical Center Otolaryngology Clinics in Los Angeles, United States.

Lavender Aromatherapy for Anxiety and Pain During Otolaryngologic Procedures

18+
All Sexes
Los Angeles, CA

The purpose of this study is to evaluate the efficacy of lavender aromatherapy in adult patients undergoing awake otolaryngologic procedures in the outpatient clinic setting. The main questions it aims to answer are: * Does lavender aromatherapy help reduce anxiety and/or pain, and improve patient comfort during awake otolaryngologic procedures in the clinic? * Do patients subjectively find aromatherapy relaxing and/or beneficial during the procedure? Researchers will compare lavender aromatherapy to placebo (an odorless liquid) to see if lavender aromatherapy helps improve patient comfort during their awake procedure Participants will: * Have their scheduled procedure performed with lavender aromatherapy or placebo during the duration of the procedure * Take a short, less than 1 minute questionnaire both before and after the procedure, describing their levels of anxiety, pain and subjective impressions of the aromatherapy

Recruiting
Paid Trial

Cedars-Sinai Medical Center Otolaryngology Clinics

Ankona Ghosh, MD

Have you considered Tussicaps clinical trials?

We made a collection of clinical trials featuring Tussicaps, we think they might fit your search criteria.
Go to Trials

Have you considered Tussicaps clinical trials?

We made a collection of clinical trials featuring Tussicaps, we think they might fit your search criteria.
Go to Trials
Image of Johns Hopkins Medicine in Baltimore, United States.

Embolization for Migraine

18 - 80
All Sexes
Baltimore, MD

This study is to test the safety and feasibility of a procedure called embolization of the middle meningeal arteries (MMA), using a product called Onyx. Embolization creates a plug in the arteries. MMA embolization with Onyx is not approved for use in patients with migraines, but is currently used in patients with subdural hematomas. The FDA is allowing the use of Onyx in this study. It is thought that by using Onyx to block the middle meningeal arteries, the amount of migraine-causing substances which are released into the brain's bloodstream will be reduced. The company that manufactures Onyx, Medtronic, is providing the supplies for this study. Participants will be in the study for about 8 months after enrolling, including 6 months of follow up after the procedure. The participants will be asked to complete a daily headache diary and continue the participant's regular migraine medications. Participants will also have several clinic visits and be asked to provide blood samples for research.

Waitlist Available
Has No Placebo

Johns Hopkins Medicine

Risheng Xu, MD, PhD

Medtronic

Image of National Institutes of Health Clinical Center in Bethesda, United States.

BPL-1357 for Flu

18 - 55
All Sexes
Bethesda, MD

Background: Influenza (flu) infections are a serious global health threat. Each year, between 3 and 5 million people get the flu, and up to 500,000 die from it. Current vaccines protect against seasonal flus, but broader vaccines are needed to protect against potential flu pandemics. Objective: To test an experimental flu vaccine. Eligibility: Healthy people aged 18 to 55 years. Design: The study will last 5 to 8 months and has 2 phases, A and B. The study vaccine will be given either as a shot in the arm or as a nasal spray. Participants will receive 1 of 3 combinations: (1) study vaccine in the nose and placebo in the arm; (2) placebo in the nose and study vaccine in the arm; or (3) placebo in the nose and placebo in the arm. A placebo is just like the real vaccine but contains no active ingredients. Phase A: Participants will have 5 clinic visits over 56 days. They will receive a shot and a nasal spray at 2 of the visits, 28 days apart. At each visit, they will have a physical exam, with tests of their blood, urine, and nasal secretions. They will check their temperature at home and record any symptoms for 7 days after each vaccine. Phase B: Participants will stay in the hospital for at least 9 days. They will be infected with a flu virus. They will provide blood, urine, and nasal fluid samples. They will have tests of their heart function. They will remain in the hospital until they test negative for the flu 2 days in a row. They will have 2 follow-up visits, 4 and 8 weeks after leaving the hospital.

Phase 2
Waitlist Available

National Institutes of Health Clinical Center (+1 Sites)

Luca T Giurgea, M.D.

Have you considered Tussicaps clinical trials?

We made a collection of clinical trials featuring Tussicaps, we think they might fit your search criteria.
Go to Trials